DYSLIPIDAEMIA
Clinical trials for DYSLIPIDAEMIA explained in plain language.
Never miss a new study
Get alerted when new DYSLIPIDAEMIA trials appear
Sign up with your email to follow new studies for DYSLIPIDAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Diet showdown: mediterranean fasting vs. Weight-Loss pill for fatty liver
Disease control ENROLLING_BY_INVITATIONThis study compares two ways to lose weight and reduce liver damage in people with cardiometabolic risks like type 2 diabetes or obesity. One group will follow a Mediterranean diet with intermittent fasting, while the other group takes a weight-loss medication (naltrexone/bupropi…
Matched conditions: DYSLIPIDAEMIA
Phase: PHASE4 • Sponsor: Carmen Dietvorst • Aim: Disease control
Last updated May 26, 2026 08:08 UTC
-
New pill aims to slash bad cholesterol in High-Risk patients
Disease control OngoingThis study tests an experimental oral drug, AZD0780, to see if it safely lowers LDL (bad) cholesterol in people with dyslipidaemia. About 432 adults in China will take the drug or a placebo daily for up to 52 weeks. The goal is to measure how well the drug reduces cholesterol lev…
Matched conditions: DYSLIPIDAEMIA
Phase: PHASE2, PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 08:08 UTC